Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Comment by GoldenIdleon Sep 16, 2021 11:18am
93 Views
Post# 33868370

RE:RE:RE:RE:SpaceLab and CandyC - The toxic retail investor

RE:RE:RE:RE:SpaceLab and CandyC - The toxic retail investorHey Papi . Time for another positive post .

I recently took a position here . I followed for awhile .

I suffer from gout , caused by high auric acid . The pill that I take was approved in 1966 . For me the trick was to get a correct diagnosis. I suffered from attacks in knees and hands , I also believe it caused several back aches . This pill I'm taking doesn't really work so good . Lifestyle change really helped me

I had a girlfriend whose father died of the kidney cyst disease . Ten years later she had contracted the same disease.

My point is there is a real need for new treatments . I don't normally invest in pharmaceuticals . But this really could be huge !
<< Previous
Bullboard Posts
Next >>